Navigation Links
Data Presented at the American Academy of Neurology Show XP13512/GSK1838262 Significantly Improved Symptoms of Moderate-to-Severe Primary Restless Legs Syndrome
Date:4/17/2008

2, -1.9) (P=0.0003). In addition, a significantly greater proportion of patients treated with XP13512 (76.1 percent) was rated as responders on the CGI-I Scale compared to placebo (38.9 percent; P<0.0001).

Sleep disturbance is often associated with RLS. In this clinical trial, patients completed the Medical Outcomes Study (MOS) Sleep Scale to assess the impact of XP13512 treatment on sleep. At Week 12, XP13512-treated patients, compared to placebo-treated patients, had statistically significant improvements in sleep quantity and sleep adequacy, as well as statistically significant reductions in sleep disturbance and daytime somnolence.

The PIVOT RLS I clinical trial used a 24-hour diary to collect the presence and severity of RLS symptoms every 30 minutes starting at 8:00 a.m. At the end of the study, more than half of patients treated with XP13512 were symptom-free for the 24-hour assessment period compared to 18 percent of placebo-treated patients.

The two most commonly reported adverse events in the study were somnolence (27 percent, XP13512 vs. 7 percent, placebo) and dizziness (20 percent, XP13512 vs. 5 percent, placebo), with the majority reported as mild-to- moderate in intensity. Nine patients (8 percent) who received XP13512 withdrew from study participation due to adverse events compared to three patients (3 percent) who received placebo. No clinically meaningful changes in vital signs or laboratory parameters were observed.

In addition, the Epworth Sleepiness Scale (ESS), a reliable tool designed to measure daytime drowsiness, was used to evaluate the likelihood of patients dozing or falling asleep in common situations of daily living, such as sitting and reading or watching TV. At Week 12, the ESS scores for patients in the XP13512 group were lower than patients in the placebo group, indicating that XP13512 treatment was associated with less daytime drowsiness. The findings on the ESS scale are consistent with the reduction in
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
2. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
3. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
4. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
5. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
6. GeoVax Successful HIV/AIDS Vaccine Trial Data Presented at AIDS Vaccine 2007 Conference
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. Promising Data from Paratek Pharmaceuticals MAR Inhibitor Program Presented in Late Breaker Session at the 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
9. New Phase III Data Presented for Once Monthly Dosing Regimen of Risedronate to Treat Postmenopausal Osteoporosis
10. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
11. Further Data on Safety and Efficacy of Cethromycin Presented at 47th Interscience Conference on Antimicrobial Agents and Chemotherapy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... ... announced the addition of the "Global ... their offering.      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) ... chromosomes using molecular biology to understand the ... It plays a crucial role in the ...
(Date:9/18/2014)... , Sept. 18, 2014  Aratana Therapeutics, ... therapeutics company focused on licensing, developing and commercializing ... the full exercise of the underwriters, option to ... connection with the company,s previously announced public offering ... the shares are being offered by Aratana Therapeutics.  ...
(Date:9/18/2014)... Ky. , Sept. 18, 2014 /PRNewswire/ ... innovative laboratory technologies and products to hospitals, ... announced today an amended distributorship agreement with ... reagents, controls and instruments, including the Sysmex ... Sysmex XP-300™, XT-Series and XN-Series Automated Hematology ...
Breaking Medicine Technology:Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 2Global Molecular Cytogenetics Market 2014-2018: Key Vendors are Abbott, Affymetrix, Agilent Technologies, F. Hoffmann-La Roche, Illumina and PerkinElmer 3Aratana Therapeutics, Inc. Announces Full Exercise of Underwriters' Option to Purchase Additional Shares 2LABSCO Renews Sysmex Distributorship Agreement 2LABSCO Renews Sysmex Distributorship Agreement 3
... ARAY ), a global leader in the ... ranked number 113 on Technology Fast 500™, Deloitte,s ranking ... life sciences and clean technology companies in North America. ... growth during the period from 2005–2009. Accuray grew 944 ...
... Oct. 20 HealthLeaders-InterStudy, a leading provider of managed ... San Diego area are looking to secure a strong ... of commercial and Medicare reimbursements by developing and growing ... will limit physician access for pharmaceutical reps. According to ...
Cached Medicine Technology:Accuray Ranked Number 113 Fastest Growing Company in North America on Deloitte's 2010 Technology Fast 500™ 2Accuray Ranked Number 113 Fastest Growing Company in North America on Deloitte's 2010 Technology Fast 500™ 3The Development of Medical Foundations in the San Diego Area will Restrict Physician Access for Pharmaceutical Reps 2
(Date:9/19/2014)... protein complexes are notoriously difficult to study with X-ray ... if not impossible, to crystallize, but also because their ... is that when a structure can be obtained it ... mosaic-like spread of protein domains that sometimes create more ... Acta Cryst . D70, 2241-2255; doi: 10.1107/S1399004714016496 ...
(Date:9/19/2014)... New York, NY (PRWEB) September 19, 2014 ... Grande presale tickets for her 2015 “Honeymoon” Tour. ... promo code ARIANA-2015 for additional savings at the checkout. , ... Kansas City, MO (Independence Event Center) , Feb. 28, 2015: ... Saint Paul, MN (Xcel Energy Center) , March 03, 2015: ...
(Date:9/19/2014)... San Jose, California (PRWEB) September 19, 2014 ... agents, an integral part of the medical imaging market, ... organs. Effervescent technology developments over the past three decades ... medical diagnostics. From barium and iodine based agents used ... as gold nanoparticles and radiopharmaceuticals, imaging agents have witnessed ...
(Date:9/19/2014)... TN (PRWEB) September 19, 2014 ... has been named a finalist for the 2014 ... founder and president Tammy Hawes has been selected ... the Year. The Nashville Area Chamber of Commerce ... these awards to recognize the accomplishments of companies ...
(Date:9/19/2014)... The results of the QUT Centre for Accident Research ... presented at the Occupational Safety in Transport Conference (OSIT) ... finishes today. , Dr Ross Blackman, a CARRS-Q road ... at risk when reduced speed limits and related traffic ... "It,s seen as crying wolf. If people are asked ...
Breaking Medicine News(10 mins):Health News:A refined approach to proteins at low resolution 2Health News:A refined approach to proteins at low resolution 3Health News:Ariana Grande Tickets in Miami, Philadelphia, Chicago, Saint Paul, Fairfax, Uncasville, Orlando, San Jose, New York, Detroit, San Antonio, Pittsburgh, Atlanta & Dallas 2Health News:Ariana Grande Tickets in Miami, Philadelphia, Chicago, Saint Paul, Fairfax, Uncasville, Orlando, San Jose, New York, Detroit, San Antonio, Pittsburgh, Atlanta & Dallas 3Health News:Ariana Grande Tickets in Miami, Philadelphia, Chicago, Saint Paul, Fairfax, Uncasville, Orlando, San Jose, New York, Detroit, San Antonio, Pittsburgh, Atlanta & Dallas 4Health News:New Clinical Applications and Advanced Imaging Capabilities Drive Growth in the Imaging Agents Market, According to New Report by Global Industry Analysts, Inc. 2Health News:New Clinical Applications and Advanced Imaging Capabilities Drive Growth in the Imaging Agents Market, According to New Report by Global Industry Analysts, Inc. 3Health News:New Clinical Applications and Advanced Imaging Capabilities Drive Growth in the Imaging Agents Market, According to New Report by Global Industry Analysts, Inc. 4Health News:Virsys12 and Founder Tammy Hawes Each Named 2014 NEXT Awards Finalists 2Health News:Virsys12 and Founder Tammy Hawes Each Named 2014 NEXT Awards Finalists 3Health News:Don't cry wolf: Drivers fed up with slowing down at inactive roadwork sites 2
... Panel of Dental Experts to Advance the , ... N.J., April 22 Milestone Scientific Inc. (OTC ... injection technologies, today announced that the Company will ... Local Anesthetic Delivery (C-CLAD) in Amelia Island, Florida. ...
... 22 Each year on the first Saturday in ... and promoted by the Pilates Method Alliance(R) (PMA(R)), ... celebrated via a network of varied, innovative, and high ... The Pilates Day mission is to foster ...
... April 22 SCAN Health Plan of Arizona announced ... to provide health tips and healthy lifestyle information to ... health plan,s ongoing commitment to improving the lives of ... the program is an ongoing series of 30-second health ...
... more greenhouse gases, researchers say , , WEDNESDAY, April 22 ... protect your health. It also may help fight ... Hygiene & Tropical Medicine say that because food production ... population, such as in Vietnam, consumes about 20 percent ...
... approaches to sex educationUNIVERSITY PARK, Pa., April 22 ... for Disease Control reports that teen pregnancy rose for ... rates appear to be rising at a slower pace ... 2007 has health officials calling for increased diligence in ...
... Supplier of the Year by UHC and Novation for ... Consortium (UHC) and Novation, the healthcare industry,s leading contracting ... Incorporated (NYSE: OMX ), a ... 2009 recipient of UHC Service Excellence Supplier Award most ...
Cached Medicine News:Health News:Milestone Scientific Hosts Second Annual Symposium on Computer-Controlled Local Anesthetic Delivery (C-CLAD) 2Health News:Milestone Scientific Hosts Second Annual Symposium on Computer-Controlled Local Anesthetic Delivery (C-CLAD) 3Health News:Pilates Day(R) Saturday May 2, 2009 2Health News:SCAN Health Plan Partners With Local Station ABC 15 to Provide Healthy Living Tips and Resources to Area Seniors 2Health News:Staying Slim Is Good for the Environment 2Health News:Penn State Conference to Address Rising Teen Pregnancy Rates 2Health News:OfficeMax Named the 2009 Recipient of The UHC Service Excellence Supplier Award 2Health News:OfficeMax Named the 2009 Recipient of The UHC Service Excellence Supplier Award 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: